The MAP Group is pleased to announce it is rebranding as Kintiga

Kintiga brings together three leading market access consultancies from across Europe and benefits from their shared, synergistic capabilities. Through its close partnership with health technology developers, Kintiga empowers its clients to expand European patient access by providing comprehensive strategic guidance, innovative solutions, and local expertise throughout the complex regulatory and payer journey.

Steve Glass, the Group CEO, commented, “The new Kintiga name and brand reflects our renewed vision and aligns our businesses under one combined strategy. While we will have a new name, we continue to offer our clients unparallelled support throughout the complex journey to achieve successful patient access across Europe, with our tailored approach, global perspective, and deep local expertise. We look forward to embracing new opportunities together as Kintiga.”

Kintiga has established operations across the UK, Ireland, Benelux, and Germany, with extensive experience across more than 200 clients in 20 markets.

About Kintiga

Kintiga is Europe’s leading independent market access and regulatory and medical affairs consultancy. Its unique capabilities enable pharmaceutical and biotech companies to maximise the value of their product portfolios, while providing patients with life-changing health solutions, by facilitating access to medicines across Europe’s complex medical, regulatory and payer environment. Kintiga also provides an online membership platform providing uninterrupted access to experts as well as an extensive and unique database, set of tools and invaluable content to its clients.